FdaApplication
BLA 761058
Identifiers
- fda_app_no: BLA761058
Properties
| Property | Value |
|---|---|
| applicant_name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2017-08-25 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYLTEZO | ADALIMUMAB-ADBM | 40MG/0.8ML | Injection |
| CYLTEZO | — | 40MG/0.4ML | Injection |
| CYLTEZO | — | 10MG/0.2ML | Injection |
| CYLTEZO | — | 20MG/0.4ML | Injection |
| CYLTEZO | — | 40MG/0.8ML | Injection |
| CYLTEZO | — | 40MG/0.4ML | Injection |
6 products